Goldman Sachs’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-55,000
| Closed | -$7.35M | – | 5920 |
|
|
2018
Q3 | $7.35M | Sell |
55,000
-2,400
| -4% | -$360K | ﹤0.01% | 2685 |
|
|
2018
Q2 | $9.13M | Buy |
+57,400
| New | +$8.51M | ﹤0.01% | 2476 |
|
|
2018
Q1 | – | Sell |
-1,100
| Closed | -$146K | – | 6615 |
|
|
2017
Q4 | $146K | Hold |
1,100
| – | – | ﹤0.01% | 5571 |
|
|
2017
Q3 | $137K | Sell |
1,100
-17,300
| -94% | -$2.38M | ﹤0.01% | 5942 |
|
|
2017
Q2 | $2.59M | Buy |
18,400
+8,900
| +94% | +$1.11M | ﹤0.01% | 3619 |
|
|
2017
Q1 | $1.07M | Sell |
9,500
-29,400
| -76% | -$3.43M | ﹤0.01% | 4313 |
|
|
2016
Q4 | $4.09M | Buy |
38,900
+10,600
| +37% | +$1.14M | ﹤0.01% | 3217 |
|
|
2016
Q3 | $3.57M | Buy |
28,300
+2,000
| +8% | +$254K | ﹤0.01% | 3341 |
|
|
2016
Q2 | $3.63M | Sell |
26,300
-18,000
| -41% | -$2.38M | ﹤0.01% | 3121 |
|
|
2016
Q1 | $6.15M | Sell |
44,300
-2,400
| -5% | -$329K | ﹤0.01% | 2586 |
|
|
2015
Q4 | $7.52M | Buy |
46,700
+10,900
| +30% | +$1.68M | ﹤0.01% | 2482 |
|
|
2015
Q3 | $4.77M | Sell |
35,800
-24,600
| -41% | -$3.21M | ﹤0.01% | 2929 |
|
|
2015
Q2 | $6.92M | Buy |
60,400
+200
| +0.3% | +$23.9K | ﹤0.01% | 2660 |
|
|
2015
Q1 | $7.19M | Sell |
60,200
-38,100
| -39% | -$5.08M | ﹤0.01% | 2567 |
|
|
2014
Q4 | $14.3M | Sell |
98,300
-8,700
| -8% | -$1.09M | ﹤0.01% | 2069 |
|
|
2014
Q3 | $14.1M | Sell |
107,000
-2,200
| -2% | -$290K | ﹤0.01% | 2086 |
|
|
2014
Q2 | $13.7M | Sell |
109,200
-19,100
| -15% | -$2.47M | ﹤0.01% | 2107 |
|
|
2014
Q1 | $20.6M | Sell |
128,300
-270,500
| -68% | -$44.5M | 0.01% | 1745 |
|
|
2013
Q4 | $53.6M | Buy |
398,800
+284,400
| +249% | +$36.5M | 0.02% | 992 |
|
|
2013
Q3 | $12.4M | Buy |
114,400
+7,400
| +7% | +$800K | ﹤0.01% | 2030 |
|
|
2013
Q2 | $9.07M | Buy |
+107,000
| New | +$9.58M | ﹤0.01% | 2183 |
|
Goldman Sachs's ATHN Position: Q1 2019 in Review
Goldman Sachs sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 350,030 shares — an estimated $46.2M sold.
Goldman Sachs first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $89.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Goldman Sachs reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Goldman Sachs sold 350,030 Athenahealth, Inc. shares in Q1 2019, an estimated $46.2M.
- Goldman Sachs first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Goldman Sachs's Athenahealth, Inc. position peaked at $89.3M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.